Your GLP-1 journey starts with one download

Through your employer benefits, you now have access to the eMed GLP-1 program. Download the eMed app to complete your at-home blood collection and unlock your program.

Enter access code:  Backto30

app store icongoogle market

Exclusive Back to 30 Partners member pricing

‍

Get the full eMed Program for:

$119.99/month*
$149.99/month

Save 20% with your Canopy Service Partners access.
Annual subscription.
Discount automatically applied with code: Backto30

*Does not include the cost of medication.

Getting started

‍

01

Download the eMed app to order your at-home Screening Kit

Your kit ships directly to you. After downloading the eMed app, enter your access code "CODE" during registration to activate your account. When your kit arrives, scan the QR code to be guided through your at-home blood collection.

02

Return your sample and receive your lab results

eMed offers two convenient return options: same-day FedEx drop-off or next-day pickup using the pre-paid box in your kit. Independent licensed clinicians then review your sample and determine your eligibility for treatment.** Your lab results will be available in the eMed app.

03

Get your prescription and start your medication

If prescribed, your medication will be delivered directly to your home. You’ll then complete your first weekly check-in through the eMed app. Ongoing support is available 24/7 whenever you need it.

‍

**Prescription medications are available only after an independent clinical evaluation by a licensed healthcare professional. Eligibility is not guaranteed. Individual health information and participation data are not shared with your employer.

Helping you improve your health confidently & privately

Whether you’re just starting or already on your GLP-1 journey

Ongoing, independent clinical care

At-home convenience

Branded, FDA-approved medication1

24/7 side effect support

Reminders & progress tracking

Lifestyle guidance through Thrive Global

1 Prescription medications are available only after an independent clinical evaluation by a licensed healthcare professional. Eligibility is not guaranteed. GLP-1 medications are prescription drugs. Important Safety Information: https://www.emed.com/important-safety-information

Clinical support that goes beyond a prescription

Weight loss is not just about medication. With eMed, you receive a structured medical program designed to help you lose weight safely, stay consistent, and build habits that support long-term health.

Access to FDA-approved branded GLP-1 medications

Care from licensed and board-certified clinicians

Personalized dosing and ongoing monitoring

Support for side effects and lifestyle guidance

Discreet, convenient home delivery

FAQ"S

Frequently asked member questions

eMed GLP-1 Weight Management Program

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

pricing

Special pricing for GLP-1 Medication

ZepBound 2.5 insulin pen injector with gray body and purple cap on white background.
Zepbound
KwikPen® (1-month supply)
2.5 mg (Starting dose)
$299
Close-up of a gray medical injector pen with a purple cap and a small display window.
Zepbound
KwikPen® (1-month supply)
5 mg (Starting dose)
$399
Close-up of a gray medical injector pen with a purple cap and a small display window.
Zepbound
KwikPen® (1-month supply)
7.5mg, 10mg, 12.5mg, 15mg
$449
Wegovy Pen 0.25 mg for subcutaneous injection on a white background.
Wegovy® Pen
4 single-use pens (1-month supply)
0.25 mg and 0.5 mg
$199*
Wegovy pen for injectable medication with dosage window on white background.
Wegovy® Pen
4 single-use pens (1-month supply)
1 mg, 1.7 mg, 2.4 mg
$349
Wegovy injectable medication pen with purple label on a light background.
Wegovy® Pen
4 single-use pens (1-month supply)
7.2 mg
$399

**Offer valid for the first 2 months (new patients only) through Decemeber 31, 2026, then $349/month

Bottle of Wegovy 2.4 mg injectable solution with a white cap and blue text on a white label.
Wegovy® Pills
Oral tablets (30-day supply)
1.5 mg and 4 mg
$149*
Bottle of Wegovy 2.4 mg injection pens for weekly diabetes treatment on white background.
Wegovy® Pills
Oral tablets (30-day supply)
9 mg and 25 mg
$299

*4 mg offer valid through August 31, 2026, then $199/month

Prices reflect self-pay pricing for eligible eMed members. Prescription required. Pricing and availability subject to change. Eligibility restrictions may apply.

‍For complete safety and efficacy information, please review the Full Prescribing Information for each product:
‍
Wegovy® Prescribing Information and Medication Guide
‍
Zepbound® Prescribing Information and Medication Guide‍
‍Wegovy and Zepbound may cause serious side effects, including:
•Possible thyroid tumors, including cancer.
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Wegovy, Zepbound, and medicines that work like them caused thyroid tumors, including thyroid cancer. It is not known if Wegovy or Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
•Do not use Wegovy or Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thryoid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

‍
‍See Indication and Important Safety Information here.

‍

PROVEN OUTCOMES

Industry leading adherence. Real results. Measured from day one.

+90
%

GLP-1 program adherence rate1

97.9
%

Reduction in prediabetes risk2

Among members with HbA1c 5.7-6.4% at enrollment

-30
lbs

Average weight lost per member2

Starting average: 220.4 lbs

1Source: Aon Workforce-Focused Analysis on GLP-1s, Phase Two Findings; January 13, 2026
2U.S. Corporate Data Partner, 2026: Based on data from a large U.S. employer client (N=638; matched lab cohort N=318 at 6 months)
Individual results vary. Outcomes are not guaranteed.

Your journey begins here

Exclusive Canopy Service Partners member pricing

‍

Get the full eMed Program for:

$119.99/month*
$149.99/month

Save 20% with your Canopy Service Partners access.
Annual subscription.
Discount automatically applied with code: Canopy!

*Does not include the cost of medication.

Clinical support that goes beyond a prescription

Weight loss is not just about medication. With eMed, you receive a structured medical program designed to help you lose weight safely, stay consistent, and build habits that support long-term health.

Access to FDA-approved branded GLP-1 medications

Care from licensed and board-certified clinicians

Personalized dosing and ongoing monitoring

Support for side effects and lifestyle guidance

Discreet, convenient home delivery

Care in a few simple steps

‍

woman holding blood device on the hand
Qualifying eligible population
Three weight loss medications: Wegovy injector pen (semaglutide), Zepbound injector pen (tirzepatide), and Wegovy Pill bottle (semaglutide).
Clinical prescribing
phone in hands
Transparent sourcing
eMed box
Supportive clinical care

‍For complete safety and efficacy information, please review the Full Prescribing Information for each product:
‍
Wegovy® Prescribing Information and Medication Guide
‍
Zepbound® Prescribing Information and Medication Guide‍
‍Wegovy and Zepbound may cause serious side effects, including:
•Possible thyroid tumors, including cancer.
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Wegovy, Zepbound, and medicines that work like them caused thyroid tumors, including thyroid cancer. It is not known if Wegovy or Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
•Do not use Wegovy or Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thryoid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

‍
‍See Indication and Important Safety Information here.

‍